Cargando…
Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU
Some physicians use dapsone as part of the standard treatment of severe COVID-19 patients entering the ICU, though some do not. To obtain an indication of whether dapsone is helping or not, we undertook a retrospective chart review of 29 consecutive ICU COVID-19 patients receiving dapsone and 30 not...
Autores principales: | Kanwar, Badar, Khattak, Asif, Kast, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779021/ https://www.ncbi.nlm.nih.gov/pubmed/36555204 http://dx.doi.org/10.3390/ijms232415563 |
Ejemplares similares
-
Benefits of Using Dapsone in Patients Hospitalized with COVID-19
por: Kanwar, Badar A., et al.
Publicado: (2022) -
NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PREDICTOR OF OUTCOMES IN PATIENTS WITH COVID-19 ADMITTED TO THE ICU
por: WAKEFIELD, CONNOR, et al.
Publicado: (2021) -
Dapsone is an anticatalysis for Alzheimer’s disease exacerbation
por: Lee, Jong Hoon, et al.
Publicado: (2022) -
Do-not-intubate status and COVID-19 mortality in patients admitted to Dutch non-ICU wards
por: van der Veer, Tjeerd, et al.
Publicado: (2021) -
Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation
por: Kast, Richard E.
Publicado: (2021)